The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

Current Market Overview

• Market Growth: The lisinopril market has experienced strong growth in recent years, expanding from $1.66 billion in 2023 to $1.76 billion in 2024. This represents a compound annual growth rate (CAGR) of 6.0%.
• Key Growth Drivers: Factors contributing to this growth include increased accessibility, lifestyle shifts, enhanced screening programs, wider availability of generic lisinopril, and improved patient adherence to treatment.

Future Growth Projections

• Market Size: Looking ahead, the lisinopril market is projected to reach $2.26 billion by 2028, with a CAGR of 6.4%.
• Growth Drivers: The forecasted growth can be attributed to several factors:
  • Rising prevalence of hypertension and cardiovascular diseases
  • Availability and cost-effectiveness of generic versions
  • Increased awareness and early diagnosis
  • Growing demand for effective treatments
  • Aging population

View More On The Lisinopril Market Report 2024 – https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

Major Trends Shaping the Market

• Innovations in Drug Delivery: There is a notable trend towards innovations in drug delivery systems to enhance patient experience and treatment effectiveness.
• Patient-Centric Approaches: Demand for more patient-centered drug delivery solutions is growing, emphasizing ease of use and accessibility.
• Cost-Effective Solutions: The need for affordable treatment options is driving market trends, especially in the context of rising healthcare costs.
• Effective Treatments for Heart Failure and Diabetic Kidney Disease: There is increasing demand for effective therapies targeting heart failure and diabetic kidney disease.

Impact of Cardiovascular Disease Rates

• Prevalence of Cardiovascular Diseases: The rise in cardiovascular diseases is a significant factor driving the lisinopril market. These diseases affect the heart and blood vessels and are linked to aging populations, lifestyle factors, and inadequate prevention strategies.
• Lisinopril’s Role: Lisinopril is effective in managing cardiovascular diseases by lowering blood pressure and reducing strain on the heart and kidneys. It works by inhibiting the production of angiotensin II, thereby facilitating blood vessel dilation and reducing blood volume.
• Recent Statistics: The Centers for Disease Control and Prevention reported a slight increase in coronary heart disease prevalence from 4.6% in 2020 to 4.9% in 2021, underscoring the need for effective treatments like lisinopril.

Major Players in the Market

• Leading Companies: Key players in the lisinopril market include Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, and Teva Pharmaceutical Industries Limited, among others.
• Recent Developments: Notably, Sun Pharmaceutical Industries Limited acquired Taro Pharmaceutical Industries Ltd. in January 2024 for $347.73 million, enhancing its portfolio with lisinopril and other specialty medicines.

Market Segmentation

• By Brand: The market includes brands such as Zestoretic, Prinivil, Zestril, and other brands.
• By Disease: Key segments include hypertension, heart failure, heart attack, strokes, diabetic kidney disease, and other conditions.
• By Dosage: Available forms include tablets, liquid, and other dosages.
• By Population Type: The market caters to both children and adults.
• By End-Users: End-users are segmented into hospitals, specialty clinics, and other facilities.

Regional Insights

• North America: This region was the largest market for lisinopril in 2023.
• Asia-Pacific: Expected to be the fastest-growing region during the forecast period, driven by increasing healthcare access and rising prevalence of hypertension.

The lisinopril market continues to grow robustly, supported by advancements in drug delivery and rising healthcare needs globally. With a strong future outlook and ongoing market developments, lisinopril remains a crucial component in managing cardiovascular diseases and improving patient outcomes.

Request A Sample Of The Global Lisinopril Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16465&type=smp